[ad_1]
At the initial stage of development, the company plans to recruit about 200 highly qualified specialists in engineering, manufacturing and research and development. Intersurgical Company plans to increase the number of employees to 10,000 in 10 years.
"The Pabrade plant is very important for our company in order to remain competitive in the medical device market," said Sigitas Žvirblis, general manager of Intersurgical UAB. "This proximity plant was one of the main reasons we chose to set up a second plant in Lithuania and not in another country."
"With two synergistic plants, we will be able to easily implement examples of good practice. S. Žvirblis
The company is already involved in the educational system of Visaginas. From 2016 Intersurgical Company offered internships to mechatronics students from Visaginas Vocational School.
"Regional development and specialization are very important for Lithuania.Intersurgical Company has managed up to 200 employees and has become one of the leading employers of Pabradė, a small town of only 6000 inhabitants. The decision to build a factory in Visaginas means that this success can be replicated and that regions can attract foreign direct investment if they have both physical and educational infrastructure, "says Mantas Katinas, general manager of the company. Invest In Lithuania and manufactures medical devices related to the maintenance of the respiratory system, the equipment manufactured in Lithuania is exported to more than 100 countries, mainly in the United Kingdom, France, Spain, Germany and Switzerland. Japan
1982 In the United Kingdom, Intersurgical is Europe's leading provider of medical devices for the support of the respiratory system. The products are used in hospitals, operating theaters, intensive care units, postoperative and other hospital facilities, ambulances and homes in more than 100 countries around the world. 1994 Intersurgical Company opened its first factory in Pabradė, Lithuania, where it currently employs nearly 2,500 employees and achieves an annual turnover of more than 100 million euros.
It is strictly forbidden to use information published by DELFI on other sites, media or elsewhere. our material in any form without consent, and if consent is obtained, it is necessary to indicate DELFI as the source.
[ad_2]
Source link